Skip to main content
. Author manuscript; available in PMC: 2019 Jan 1.
Published in final edited form as: Antiviral Res. 2017 Nov 26;149:211–220. doi: 10.1016/j.antiviral.2017.11.015

Fig. 4.

Fig. 4

Top view of an HBc hexamer in complex with CAM sulfamoylbenzamide SBA_R01, PDB: 5T2P (Left) and CAM heteroaryldihydropyrimidine HAP_R01 PDB: 5WRE (Zhou et al., 2017) (Right).